{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:26:04Z","timestamp":1771608364927,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ygyno.2026.01.003","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T17:18:31Z","timestamp":1768065511000},"page":"32-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Leveraging tumor multigene panel testing to identify germline variants in gynecologic cancers: A retrospective evaluation of an algorithm-based approach"],"prefix":"10.1016","volume":"205","author":[{"given":"Maitreyee","family":"Parulekar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo-Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kidong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sejoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hong","family":"No","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Beom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2026.01.003_bb0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12032-021-01454-5","article-title":"Prevalence of mutations in the BRCA and MMR genes in patients with hereditary endometrial cancer","volume":"38","author":"Vietri","year":"2021","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ygyno.2026.01.003_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/341723","article-title":"Hereditary ovarian cancer: not only BRCA1 and 2 genes","volume":"2015","author":"Toss","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.ygyno.2026.01.003_bb0015","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4143\/crt.2021.828","article-title":"Frequency of mismatch repair deficiency\/high microsatellite instability and its role as a predictive biomarker of response to immune checkpoint inhibitors in gynecologic cancers","volume":"54","author":"Noh","year":"2021","journal-title":"Cancer Res. Treat."},{"issue":"11","key":"10.1016\/j.ygyno.2026.01.003_bb0020","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.3390\/cancers12113319","article-title":"Gynecological cancers caused by deficient mismatch repair and microsatellite instability","volume":"12","author":"Deshpande","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2026.01.003_bb0025","first-page":"43","article-title":"Aligning germline cancer predisposition with tumor-based next-generation sequencing for modern oncology diagnosis, interception, and therapeutic development","volume":"43","author":"Yap","year":"2023","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"1","key":"10.1016\/j.ygyno.2026.01.003_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-023-02228-x","article-title":"Comprehensive genomic profiling for oncological advancements by precision medicine","volume":"41","author":"Pankiw","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ygyno.2026.01.003_bb0035","unstructured":"Society of Gynecologic Oncology. Germline and somatic testing for ovarian cancer: an SGO clinical practice statement. 2024. Available from: https:\/\/www.sgo.org."},{"key":"10.1016\/j.ygyno.2026.01.003_bb0040","unstructured":"National Comprehensive Cancer Network. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic. Version 1. 2024. Available from: https:\/\/www.nccn.org."},{"issue":"1","key":"10.1016\/j.ygyno.2026.01.003_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2026.01.003_bb0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J. Mol. Diagn."},{"issue":"8","key":"10.1016\/j.ygyno.2026.01.003_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27351","article-title":"Germline variants incidentally detected via tumor-only genomic profiling of patients with mesothelioma","volume":"6","author":"Mitchell","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ygyno.2026.01.003_bb0060","article-title":"Germline sequencing improves tumor-only sequencing interpretation in a precision genomic study of patients with pediatric solid tumor","volume":"5","author":"Schienda","year":"2021","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.ygyno.2026.01.003_bb0065","article-title":"Addition of germline testing to tumor-only sequencing improves detection of pathogenic germline variants in men with advanced prostate cancer","volume":"6","author":"Berchuck","year":"2022","journal-title":"JCO Precis. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2026.01.003_bb0070","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S1470-2045(21)00531-3","article-title":"Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1\/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"22","author":"Banerjee","year":"2021","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2026.01.003_bb0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2026.01.003_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12885-020-07749-6","article-title":"The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis","volume":"21","author":"Moslemi","year":"2021","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2026.01.003_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40291-018-0344-x","article-title":"Association between CHEK2*1100delC and breast cancer: a systematic review and meta-analysis","volume":"22","author":"Liang","year":"2018","journal-title":"Mol. Diagn. Ther."},{"issue":"8","key":"10.1016\/j.ygyno.2026.01.003_bb0090","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/jpm14080866","article-title":"Germline RAD51C and RAD51D mutations in high-risk Chinese breast and\/or ovarian cancer patients and families","volume":"14","author":"Kwong","year":"2024","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ygyno.2026.01.003_bb0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ygyno.2023.11.019","article-title":"Pathogenic germline variants in non-BRCA1\/2 homologous recombination genes in ovarian cancer: analysis of tumor phenotype and survival","volume":"180","author":"Kahn","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.01.003_bb0100","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1200\/JCO.18.00283","article-title":"Microsatellite instability is associated with the presence of lynch syndrome pan-cancer","volume":"37","author":"Latham","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.01.003_bb0105","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a006280","article-title":"Mismatch repair-deficient glioma with spatially distinct IDH-mutant and IDH-wild type components arising in the setting of lynch syndrome","volume":"9","author":"Tan","year":"2023","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"issue":"1","key":"10.1016\/j.ygyno.2026.01.003_bb0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12881-018-0691-9","article-title":"Detecting clinically actionable variants in the 3\u2032 exons of PMS2 via a reflex workflow based on equivalent hybrid capture of the gene and its pseudogene","volume":"19","author":"Gould","year":"2018","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ygyno.2026.01.003_bb0115","article-title":"Tumor-only sequencing detects germline mutations in cancer susceptibility genes","volume":"9(403):eaal2649","author":"Mandelker","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.ygyno.2026.01.003_bb0120","first-page":"676","article-title":"Reassessing the frequency of germline pathogenic variants among patients with a cancer predisposition","volume":"22","author":"Lincoln","year":"2020","journal-title":"Genet. Med."},{"issue":"7","key":"10.1016\/j.ygyno.2026.01.003_bb0125","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/jpm11070593","article-title":"Reliability of tumor testing compared to germline testing for detecting BRCA1 and BRCA2 mutations in patients with epithelial ovarian cancer","volume":"11","author":"Bekos","year":"2021","journal-title":"J. Pers. Med."},{"issue":"36","key":"10.1016\/j.ygyno.2026.01.003_bb0130","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1200\/JCO.2015.63.9518","article-title":"Combined microsatellite instability, MLH1 methylation analysis, and immunohistochemistry for lynch syndrome screening in endometrial cancers from GOG210: an NRG oncology and gynecologic oncology group study","volume":"33","author":"Goodfellow","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.01.003_bb0135","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1078-0432.CCR-18-1443","article-title":"Frequent homologous recombination deficiency in high-grade endometrial carcinomas","volume":"25","author":"de Jonge","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ygyno.2026.01.003_bb0140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.01.003_bb0145","first-page":"325","article-title":"Frequent mutations in DNA repair genes in cervical small cell neuroendocrine carcinoma","volume":"150","author":"Miyatake","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2026.01.003_bb0150","first-page":"582","article-title":"P53 mutations in vulvar squamous cell carcinoma and its precursors: correlation with HPV and clinical outcomes","volume":"25","author":"Garg","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2026.01.003_bb0155","first-page":"20","article-title":"The spectrum of TP53, BRCA1\/2, and PTEN mutations in early onset gynecologic cancers","volume":"18","author":"Kupryjanczyk","year":"2020","journal-title":"Hered Cancer Clin. Pract."},{"issue":"2","key":"10.1016\/j.ygyno.2026.01.003_bb0160","first-page":"352","article-title":"Detection of germline mutations via tumor-normal paired next-generation sequencing in ovarian cancer","volume":"166","author":"Yoshida","year":"2022","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582600003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582600003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:54:40Z","timestamp":1771606480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582600003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"alternative-id":["S009082582600003X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.01.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leveraging tumor multigene panel testing to identify germline variants in gynecologic cancers: A retrospective evaluation of an algorithm-based approach","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}